Authors:
Wang, JY
Pasetti, MF
Noriega, FR
Anderson, RJ
Wasserman, SS
Galen, JE
Sztein, MB
Levine, MM
Citation: Jy. Wang et al., Construction, genotypic and phenotypic characterization, and immunogenicity of attenuated Delta guaBA Salmonella enterica serovar Typhi strain CVD 915, INFEC IMMUN, 69(8), 2001, pp. 4734-4741
Authors:
Gomez-Duarte, OG
Pasetti, MF
Santiago, A
Sztein, MB
Hoffman, SL
Levine, MM
Citation: Og. Gomez-duarte et al., Expression, extracellular secretion, and immunogenicity of the Plasmodium falciparum sporozoite surface protein 2 in Salmonella vaccine strains, INFEC IMMUN, 69(2), 2001, pp. 1192-1198
Authors:
Pasetti, MF
Pickett, TE
Levine, MM
Sztein, MB
Citation: Mf. Pasetti et al., A comparison of immunogenicity and in vivo distribution of Salmonella enterica serovar Typhi and Typhimurium live vector vaccines delivered by mucosal routes in the murine model, VACCINE, 18(28), 2000, pp. 3208-3213
Citation: Rj. Anderson et al., Delta guaBA attenuated Shigella flexneri 2a strain CVD 1204 as a Shigella vaccine and as a live mucosal delivery system for fragment C of tetanus toxin, VACCINE, 18(21), 2000, pp. 2193-2202
Authors:
Pickett, TE
Pasetti, MF
Galen, JE
Sztein, MB
Levine, MM
Citation: Te. Pickett et al., In vivo characterization of the murine intranasal model for assessing the immunogenicity of attenuated Salmonella enterica serovar typhi strains as live mucosal vaccines and as live vectors, INFEC IMMUN, 68(1), 2000, pp. 205-213
Citation: Mf. Pasetti et al., Attenuated Delta guaBA Salmonella typhi vaccine strain CVD 915 as a live vector utilizing prokaryotic or eukaryotic expression systems to deliver foreign antigens and elicit immune responses, CLIN IMMUNO, 92(1), 1999, pp. 76-89